Lung Cancers Not Yet Recruiting Phase 2 Trials for Aprepitant (DB00673)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02445872Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin ChemotherapySupportive Care